This week's IL newsletter: Weight loss jabs – Access remains deeply unequal, yet public interest in Mounjaro, Wegovy and Ozempic is soaring. #WeightLossJabs #NHSAccess #HealthInequality #DisabilityAndHealth #IndependentLiving #ILnews
buff.ly/Kd9OqDF

Novo Nordisk shares nosedive as Mounjaro, copycat weight loss drugs threaten market lead Novo Nordisk’s shares fell by more than 20% on Tuesday

Novo Nordisk shares tumble as Mounjaro takes weight‑loss lead

#NovoNordisk #Mounjaro #Wegovy #WeightLossDrugs #GLP1 #EliLilly #ObesityCrisis #PharmaNews #HealthTech #StockMarketCrash #ObesityTreatment #NHSAccess #MedicalNews

www.easterneye.biz/weight-loss-...

Translation services within healthcare settings - Healthwatch Westmorland and Furness Have you found NHS translation services in South Cumbria difficult? You're not alone. Read about Luiz and Sara's experience here.

New story 🚨

Luiz, a South Cumbria resident, faced barriers accessing healthcare due to a lack of translation support.

With help from Healthwatch, he and his partner made real change.

Read more 👉 https://bit.ly/43iHF8t

📞 info@healthwatchwestfurn.co.uk | 0300 373 2820
#NHSAccess #TranslationRights

LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema LEO Pharma has secured marketing authorisation from the MHRA for its innovative treatment, Anzupgo® (delgocitinib) cream, marking a breakthrough for adults with moderate to severe Chronic Hand Eczema ...

www.linkedin.com/pulse/leo-ph...

LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema

#LEOPharma #ChronicHandEczema #AnzupgoCream #Delgocitinib #SkinHealth #NHSAccess #MedicalBreakthrough #HealthcareInnovation #Humanteconomy #Humantec